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Meta-analysis comparing same-day versus delayed 
vitrectomy clinical outcomes for intravitreal 
retained lens fragments after age-related 
cataract surgery
elizabeth a Vanner1
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Pathology and Bioinformatics, stony 
Brook University, stony Brook, nY, 
Usa; 2Department of Ophthalmology, 
Mayo Clinic College of Medicine, 
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Purpose/design: We aimed to perform a systematic review and meta-analysis comparing the 
risk difference of clinical outcomes for same-day (SD) vs delayed (DEL) pars plana vitrectomy 
(PPV).
Methods: We searched MEDLINE (English; January 1, 1985 to July 16, 2013) and article 
reference lists, for patients with crystalline retained lens fragments and discussion of SD-PPV 
vs DEL-PPV. For the meta-analysis, articles needed the number of patients receiving SD-PPV 
and DEL-PPV, and the number, in each group, who experienced one or more of the outcomes: 
not good visual acuity (VA) (,20/40), bad VA (#20/200), retinal detachment, increased 
intraocular pressure/glaucoma, intraocular infection/inflammation, cystoid macular edema, 
and corneal edema.
Results: Of 304 articles identified, 23 provided data for the meta-analysis. Results were mixed, 
indicating 1) neither vitrectomy time produced better outcomes in all studies (not good VA risk dif-
ference =10.3% [positive numbers favored SD-PPV; negative numbers favored DEL-PPV], 95% 
confidence interval [CI] = [-0.4% to 21.0%], P=0.059; and bad VA risk difference =-0.3%, 95% 
CI = [-10.7% to 10.1%], P=0.953); 2) better outcomes with immediate SD-PPV compared with all 
DEL-PPV (not good VA risk difference =16.2%, 95% CI = [0.8% to 31.5%], P=0.039; and bad VA 
risk difference =8.5%; 95% CI = [0.8% to 16.2%], P=0.030); and 3) immediate SD-PPV and prompt 
DEL-PPV (3 to 14 days after cataract surgery) had no significant differences and so may produce 
similar outcomes (not good VA risk differences range = [-19.9% to 6.5%], 95% CI = [-59.9% to 
36.4%]; and bad VA risk differences range = [-6.9% to 7.4%], 95% CI = [-33.1% to 31.8%]).
Conclusion: Perhaps SD-PPV should be limited to facilities at which a vitreoretinal surgeon 
is immediately available. Otherwise, these results support referring a patient with retained 
lens fragments promptly to a vitreoretinal surgeon but do not support interfacility transport 
for SD-PPV.
Keywords: retained lens fragments, vitrectomy, time factors, visual acuity, meta-analysis, 
systematic review
Introduction
Phacoemulsification lensectomy1 occasionally results in retained lens fragments or 
the entire crystalline lens dislocating into the vitreous, which increases the risk of 
postoperative complications and vision loss.2,3 With an estimated 10 million cataract 
surgeries performed per year worldwide,4 the estimated annual incidence of retained 
lens fragments is between 10,000–160,000 (mean =85,000). The timing of pars plana 
vitrectomy (PPV) to remove retained lens fragments is controversial, especially 
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concerning whether, and under what circumstances, a “same 
day” (SD) (as the cataract surgery) vitrectomy (SD-PPV) 
might be performed. Optimal management of retained lens 
fragments has not been determined, but cataract surgeons 
have been urged to avoid attempting to retrieve retained lens 
fragments by manipulating the vitreous,5,6 to prevent com-
plications such as retinal detachment,7 and to refer patients 
to a vitreoretinal surgeon promptly.8–13
Some vitreoretinal surgeons suggest performing an SD-
PPV, as they believe this to be the optimal time to remove 
retained lens fragments.14,15 However, the logistics of arrang-
ing an SD-PPV can be daunting.16,17 Others feel that SD-PPV 
is unnecessary, complicates the informed consent process, 
and may increase the risk of complications.18,19 A survey of 
cataract surgeons indicated they believed that 58% of patients 
had retained lens fragments removed immediately,20 far 
higher than reported by vitreoretinal surgeons, who indicated 
only 13% (536 of 4,150) of eyes received an SD-PPV.21
Policies for performing SD-PPV differ among facili-
ties. Lack of the necessary equipment and/or the immediate 
availability of an experienced vitreoretinal surgeon may 
preclude an SD-PPV.22 Preliminary examination of the SD-
PPV results in the literature23 found that some facilities had 
good visual acuity (VA) results,22,24,25 while other facilities’ 
results were not as good26–28 (data not shown). Reasons for 
this dichotomy were not clear, but lower rates of increased 
intraocular pressure (IOP) and cystoid macular edema 
(CME) with SD-PPV may be related to reduced intraocular 
inflammation/infection.24 Several authors reported better VA 
and lower rates of complications (including retinal detach-
ment, increased IOP, corneal edema, CME, and intraocular 
inflammation/infection) among patients who had SD-PPV 
compared with delayed vitrectomy (DEL-PPV), but these dif-
ferences were not always statistically significant.25,29–31 Other 
authors reported little or no differences in these and other 
outcomes when comparing SD-PPV and DEL-PPV.32–34
This is our second meta-analysis about vitrectomy tim-
ing for retained lens fragments. The first, which included no 
SD-PPV patients, indicated that prompt DEL-PPV (3 to 7 or 
possibly 3 to 14 days after cataract surgery) was associated 
with better VA and fewer cases of previtrectomy and postvit-
rectomy retinal detachment, increased IOP, and intraocular 
inflammation/infection compared with later (nonprompt) 
DEL-PPV.13 As in our previous study, the primary out-
comes for this meta-analysis were not good VA (,20/40) 
and bad VA (#20/200). Secondary outcomes included 
retinal detachment, increased IOP, intraocular inflammation/
infection, CME, and corneal edema. All outcome data were 
postvitrectomy, preferably at final examination. The aim 
of this research was to explore 1) differences in clinical   
outcomes between SD-PPV and DEL-PPV, 2) the observed 
heterogeneity in SD-PPV results, and 3) the effect of policy 
differences on SD-PPV results. Complete citations and 
greater detail may be found in the first author’s doctoral 
dissertation,21 which is available upon request. All refer-
ences to our previous research are to this dissertation and 
the authors’ previous meta-analysis.13
Materials and methods
search strategy
Details of the article search for the systematic review and 
meta-analyses of the literature on retained lens fragments 
timing were described previously13,21 and are summarized 
in Figure S1. The publication date range for the MEDLINE 
search was January 1, 1985 to July 16, 2013. All study 
designs were considered, and no previous meta-analysis 
comparing SD-PPV and DEL-PPV outcomes was found. 
Internal review board approval and informed consent are 
not required for a meta-analysis.
inclusion criteria
A study was included in the meta-analysis if it contained at 
least ten patients who received a vitrectomy for intravitreal 
retained lens fragments after surgery for an age-related cata-
ract; had mean follow-up of at least 3 months; and had results 
for both SD-PPV and DEL-PPV patients, including the 
number receiving each treatment (SD-PPV and DEL-PPV), 
and the number in each treatment group who experienced at 
least one of the outcomes.
Data extraction
For each study/outcome combination, the number of patients 
was recorded, separately for those who did and did not 
experience that outcome, for SD-PPV and DEL-PPV. Our 
previous research indicated that when an SD-PPV was not 
performed, a vitreoretinal surgeon should wait at least 3 days 
after cataract surgery before attempting a vitrectomy unless 
severe complications preclude a delay. Therefore, whenever 
possible, DEL-PPVs were limited to those performed at least 
3 days after cataract surgery. Additional details of the data 
extraction were described previously.13,21
Study classification
The Mayo Clinic Florida (MCF) SD-PPV policy permits an 
SD-PPV under a “no move, no wait” policy only if a vitreo-
retinal surgeon begins the vitrectomy within 15 minutes of Clinical Ophthalmology 2014:8 submit your manuscript | www.dovepress.com
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cataract surgery and the patient is not moved from the original 
operating room. In addition, the policy precludes cataract 
surgeons from attempting to remove intravitreal retained 
lens fragments.35 Based on the information available, articles 
were classified as MCF+ if their SD-PPVs met criteria similar 
to those at the MCF and as MCF- if their SD-PPVs did not 
meet these criteria.
The three criteria were SD-PPVs performed 1) at   
the same facility as the cataract surgery, 2) with only a 
short time between cataract surgery and vitrectomy, and 
3) without any cataract surgeons attempting to remove the 
intravitreal retained lens fragments. SD-PPV was coded as 
“same facility” if the authors indicated immediate vitrectomy, 
vitrectomy at the time of cataract surgery, or that SD-PPV 
was possible only if cataract surgery was done in a facility 
where a vitreoretinal surgeon was available. SD-PPV was 
coded as “a short time between cataract surgery and vitrec-
tomy” if the authors indicated this explicitly or implied this, 
for example: immediate, converted to vitrectomy, or same 
operating room. SD-PPV was coded as “different facility” 
and/or “not a short time between cataract surgery and vit-
rectomy” if the above conditions were not met and/or if the 
authors indicated that some or all of the SD-PPV patients 
were “referred to our facility”. All facilities were coded based 
on whether the authors indicated that any cataract surgeons 
attempted to remove intravitreal retained lens fragments for 
SD-PPV patients during cataract surgery.
estimating the effect for each study
The summary effect for the meta-analysis was the risk dif-
ference of patients experiencing each outcome between the 
SD-PPV and DEL-PPV treatment groups. To estimate the 
risk difference in the population, using sample data from 
each study, the observed risk was determined by dividing the 
number of events (occurrence of the adverse outcome, such 
as retinal detachment) in each treatment group (SD-PPV and 
DEL-PPV) by the number of patients in that group. The risk 
difference for each study was the proportion of DEL-PPV 
patients minus the proportion of SD-PPV patients, so posi-
tive numbers “favored” (indicated superior outcomes with) 
SD-PPV, while negative numbers favored DEL-PPV.
When possible, the variance for each risk difference 
was estimated using the standard formula for estimating 
the variance of a risk difference.36 However, when there 
were no events (or no nonevents) in a study treatment 
group (SD-PPV and/or DEL-PPV), the variance was esti-
mated using the observed proportion of events in the total 
sample (SD-PPV plus DEL-PPV groups) for that study or 
the overall proportion of events (in that treatment group) in 
all studies.21 The effect of including studies whose variance 
was not estimated using the standard formula for estimat-
ing the variance of a risk difference was assessed with a 
sensitivity analysis.
statistical analyses
Meta-analyses were performed using Comprehensive Meta-
Analysis, version 2.2 (Biostat Inc., Englewood, NJ, USA). As 
in our previous research, random-effects models were used in 
the main meta-analyses. All additional meta-analyses, which 
compared subgroups of studies, used mixed-effect models, 
combining studies within subgroups using random-effects 
models but combined subgroups using fixed-effects models. 
These mixed-effect models did not assume a common vari-
ance across subgroups (no pooling of variance), but rather, 
the variance in each subgroup was estimated separately. 
These additional analyses assessed how results differed 
between MCF+ and MCF- studies and, for MCF+ stud-
ies only, by the timing of the DEL-PPV. We also assessed 
effects of reporting and publication biases, including studies 
whose variance was not estimated using the standard formula 
(discussed above), and assessed whether the results were 
robust with sensitivity analyses.37,38 Results were statistically 
significant with P-value #0.05 and marginally significant 
with 0.05,P#0.15.35,39
Results
search results
A total of 304 articles were identified (230 through PubMed 
and 74 from other sources, including articles’ reference lists), 
with 128 excluded based on reading the title and abstract. Full 
text of the remaining 176 articles was retrieved and reviewed. 
A total of 76 articles were included in the systematic review 
of the retained lens fragments literature. However, only 
23 articles with 21 unique study cohorts had the data neces-
sary for the SD-PPV vs DEL-PPV meta-analysis.
In one article,40 there were data for only the study (not the 
control) group, so only these patients were included. All the 
patients in Kim et al22 and Moore et al7 were also in Modi et al32   
but no patients were double-counted. Modi et al32 was used 
for VA, CME, and corneal edema; Moore et al7 was used for 
retinal detachment; and Kim et al22 was used for increased 
IOP and intraocular inflammation/infection. This was done 
to preferentially use data for final outcomes rather than for 
outcomes any time after the vitrectomy. Nine (39%) articles 
were MCF- and 14 (61%) were MCF+ (see the “Study 
classification” section). A summary of the initial search results   Clinical Ophthalmology 2014:8 submit your manuscript | www.dovepress.com
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of the “retained lens fragments timing” literature appeared 
previously.13 Figure 1 contains a summary, in the standard 
format,41 of the updated search results.
Table 1 contains details for the 23 articles (21 studies). 
The studies’ locations were: six of 21 from the USA/Canada 
(29%), nine from Europe (43%), five from Asia (24%), and 
one from Australia (5%). Patients were treated from 1988 
to 2011, so overall, there were 24 years of service for all the 
studies collectively, with an average of 6.6 years of service 
per study (range 1 to 22 years of service). The studies tended 
to be small, with 17 (81%) including fewer than 100 patients. 
Collectively, studies included in the meta-analysis had data for 
1,606 eyes, with a mean of 76.5 eyes per study (median =25;   
range 12 to 569 eyes). Of these, 1,596 (99.4%) eyes received a 
vitrectomy (article range 83% to 100%), and ten eyes (0.6%) 
received medical management. Of the eyes that received a 
vitrectomy, 337 (21%) received an SD-PPV and 1,259 (78%) 
received a DEL-PPV. Approximately 52% of the patients 
were female, with an average age of 74.2 years (study means 
range from 54 to 78 years). Including the SD-PPV patients, 
the average time between cataract surgery and vitrectomy 
was 13.8 days (study mean range 1.7 to 41 days), and mean 
follow-up time was approximately 13.6 months (study mean 
range 3 to 63 months).
Quality analysis
Overall quality issues were similar to those in our previous 
meta-analysis.13 In 18 (78%) of 23 articles, patients were a 
consecutive series (a representative sample of the popula-
tion), but only one (4%) article was a prospective study. 
In 21 (91%) articles, the years of service were stated, all 
patients were accounted for, and patients’ characteristics 
Figure 1 Flowchart of the updated articles search for the systematic review and meta-analyses of the retained lens fragment timing literature with publication dates January 1,   
1985 through July 16, 2013. 
Notes: secondary articles contained data for patients who were also in another article.
Abbreviations: Cs, cataract surgery; Del, delayed; Ma, meta-analysis; PPV, pars plana vitrectomy; sD, same day; sr, systematic review; Va, visual acuity; vs, versus.
304 articles identified: 230 through PubMed and 74 through article references,
BioMedLib, and a trade journal
128 articles excluded based on title
and/or abstract
176 articles retrieved for detailed evaluation
76 articles passed initial screen for the SR
100 articles excluded with initial screen
Different research question
Not retained lens fragments
Editorial article
Review article
Surgical techniques only
Not age-related cataracts
PPV not used
Not crystalline lens
Not CS
Out of date range
Total
38
14
10
7
14
4
4
2
6
1
100
41 articles for the meta-analyses
Both meta-analyses
DEL (3+ days post-CS) MA
SD- vs DEL-PPV MA
Total
16
18
7
41
23 articles for systematic review analyses
Both power and poor final
VA analyses
Poor final VA analysis only
Power analysis only
3
18
2
Total 23
12 articles for SR qualitative analysis
SD-PPV only
DEL-PPV only
Medical/surgical only
Data not useable
No useable time periods
Not enough cases
Subtotal
Secondary article
Total
1
1
1
1
1
1
6
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Vanner and stewart
at presentation were reported. Reasons were given for all 
lost/excluded patients in 20 (87%) articles, but in only 
17 (74%) articles was information reported on all patients 
excluded for missing data or loss to follow-up. In 14 (61%) 
articles, the authors specified standardized assessments of 
outcomes, and in 13 (57%) articles, the authors indicated 
their criteria for treatment choice (vitrectomy timing). Only 
eleven (48%) articles reported preexisting ocular comorbidi-
ties and actual P-values.
Also, using the Minckler42 evidence-based rating sys-
tem, for clinical importance, 19 (83%) articles were rated 
A, one (4%) article was rated B, and three articles were 
rated C (13%). For Minckler’s other criterion, strength 
of evidence, all articles were rated III (weak), mainly 
because the research was retrospective. Two (9%) articles 
reported data for all seven outcomes, two (9%) articles for 
six outcomes, five (22%) articles for five outcomes, three 
(13%) articles for four outcomes, three (13%) articles for 
three outcomes, four articles (17%) for two outcomes, and 
four (17%) articles for one outcome. Five (22%) articles 
had average follow-up time between 3 and 6 months, nine 
(39%) articles between 6 and 12 months, six (26%) articles 
between 12 and 24 months, and three (13%) articles for 
more than 24 months.
Statistical significance analysis
Our previous research discussed low statistical power in the 
retained lens fragments timing literature. The analysis estimat-
ing each study’s power for comparing outcomes was updated, 
and the results (mean =24%, median =14%) again indicated 
that many studies had low power. Figure 2A shows whether 
SD-PPV or DEL-PPV seemed better for each outcome, for 
all articles with these data.2,3,6,7,11,12,14,15,17–19,22,24–27,29–31,34,35,40,43–45 
These SD-PPV vs DEL-PPV results appear mixed and do not 
obviously favor either vitrectomy time.
Main sD-PPV vs Del-PPV meta-analysis
These results (Table 2) favored SD-PPV for all outcomes 
except bad VA, remembering that a positive risk difference 
“favored” (indicated superior outcomes with) SD-PPV, while 
a negative risk difference favored DEL-PPV. However, only 
one of the results among the outcomes that favored SD-PPV 
(not good VA, retinal detachment, increased IOP, intraocular 
inflammation/infection, CME, and corneal edema) was 
B
VA
RD
IOP
IOI
CME
CE
0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100%
VA
RD
IOP
IOI
CME
CE
0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100%
Favors SD-PPV, significant (P≤0.05)
Favors SD-PPV, nonsignificant (0.5>P>0.05)
No influence/unclear (P≥0.5)
Favors DEL-PPV, nonsignificant (0.5>P>0.05)
Favors DEL-PPV, significant (P≤0.05)
0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100%
VA
RD
IOP
IOI
CME
CE
C A
Figure 2 indication of which PPV timing, sD-PPV or Del-PPV had better outcomes, for all studies (all sD- vs Del-PPV articles) (A), MCF+ studies (B), and MCF- studies (C).
Abbreviations: CE, corneal edema; CME, cystoid macular edema; DEL-PPV, delayed PPV; IOI, intraocular inflammation/infection; IOP, increased intraocular pressure;   
MCF, Mayo Clinic Florida; MCF-, studies not adhering to MCF sD-PPV policies; MCF+, studies adhering to MCF sD-PPV policies; PPV, pars plana vitrectomy; rD, retinal 
detachment; sD-PPV, same-day PPV; Va, visual acuity; vs, versus.Clinical Ophthalmology 2014:8 submit your manuscript | www.dovepress.com
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same-day versus delayed vitrectomy outcomes for lens fragments
statistically significant. The IOP results indicated a significant 
risk difference of 7.0% between SD-PPV and DEL-PPV 
(P=0.042 [z-test], 95% confidence interval = [0.2% to 
13.8%]). Also, the corneal edema results were heavily influ-
enced by a single case, which was the only SD-PPV patient 
in one study.6 These results do not provide enough evidence 
to indicate a consistent association between clinical outcomes 
and vitrectomy timing (SD-PPV or DEL-PPV) and agree with 
the statistical significance analysis in Figure 2A.
separate MCF+ and MCF- meta-analyses
Another statistical significance analysis, with studies 
separated into MCF+ (Figure 2B) and MCF- (Figure 2C), 
indicted that SD-PPV might have produced better out-
comes in MCF+ studies2,7,11,17–19,22,24,25,27,30,32,35,40,44,45 but 
not in MCF- studies.3,6,12,14,15,26,29,31,34,43 Table 3 compares 
the percent of SD-PPV and DEL-PPV patients with each 
outcome, by MCF policy status. Figures 2B and 2C, along 
with the data in Table 3, support a hypothesis that the risk 
differences between immediate SD-PPV and DEL-PPV 
(in MCF+ studies) more consistently favor SD-PPV than 
the risk differences between nonimmediate SD-PPV and 
DEL-PPV (in MCF- studies).
Therefore, meta-analyses were done separately for the 
MCF+ and MCF- studies, and these results differed from 
those done with all the studies combined (compare Tables 2 
and 4). For the MCF+ studies, all results favored SD-PPV 
(except intraocular inflammation/infection, which was 
essentially neutral). For five of seven outcomes (not good 
VA, bad VA, retinal detachment, increased IOP, and corneal 
edema), the effect favoring SD-PPV was statistically signifi-
cant. In the MCF+ studies, the number needed to treat, with 
immediate SD-PPV rather than DEL-PPV, to avoid all five 
statistically significant outcomes, was four.36 This provided 
some evidence that immediate SD-PPVs (performed accord-
ing to policies similar to the MCF SD-PPV policies) produced 
better outcomes than DEL-PPVs.
For the MCF- studies, three outcomes favored SD-PPV 
(not good VA, increased IOP, and intraocular inflammation/
infection) and four favored DEL-PPV (bad VA, retinal 
detachment, CME, and corneal edema). The only significant 
(corneal edema) or marginally significant (bad VA) effects 
favored DEL-PPV. Based on these mixed, mostly nonsignifi-
cant results, there was little evidence to favor either vitrec-
tomy timing (SD-PPV or DEL-PPV) for the MCF- studies, 
so further analyses were limited to the MCF+ studies only.
An examination of the forest plot from the not good VA 
meta-analysis (Figure 3) visually supported a conclusion that 
the estimated summary risk difference did not indicate better 
outcomes with either SD-PPV or DEL-PPV for the MCF- 
studies (top) but did indicate better outcomes with immediate 
SD-PPV for the MCF+ studies (bottom). The forest plots for 
the remaining outcomes (not shown) were similar.
subgroup analysis: Del-PPV time 
after cataract surgery (MCF+ only)
The results of our previous meta-analysis indicated, for vit-
rectomies performed 3 or more days after cataract surgery, 
that prompt (earlier) vitrectomies (3 to 7 or 3 to 14 days 
after cataract surgery) provided better outcomes (for not 
good VA, bad VA, retinal detachment, increased IOP, and 
intraocular inflammation/infection).13 Based on these results, 
we investigated whether superior outcomes for immediate 
SD-PPV (in MCF+ studies) were sensitive to the time until 
Table 2 Main same-day versus delayed vitrectomy meta-analysis results (random effects models) estimated summary risk differences 
for all studies that had data for that outcome
Outcome Studies 
N
RiskDiff 95% CI Z-score** P-value I2*** SD better§ 
N
DEL better‡ 
N
No difference#
N
Va not good 20 10.3% (-0.4%, 21%) 1.886 0.059† 46.191 12 8 0
Va bad 15 -0.3% (-10.7%, 10.1%) -0.059 0.953 52.025 7 7 1
retinal detachment 12 3.1% (-3.0%, 9.3%) 0.995 0.320 32.317 7 3 2
iOP/glaucoma 13 7.0% (0.2%, 13.8%) 2.031 0.042* 24.282 8 4 1
iOi 11 1.0% (-1.6%, 3.7%) 0.755 0.450 0.000 5 2 4
CMe 7 1.8% (-3.1%, 6.7%) 0.732 0.464 0.000 5 2 0
Corneal edema 5 2.6% (-7.3%, 12.5%) 0.518 0.605 68.588 4 1 0
Notes: *P#0.05,  †P#0.15 (marginally significant). **Statistic for comparing the risk difference of SD-PPV and DEL-PPV patients. ***Indication of heterogeneity among 
individual study risk difference estimates in the fixed effects model. §number of studies in which the sD-PPV patients experienced better clinical outcomes; ‡number of studies 
in which Del-PPV patients experienced better clinical outcomes; #number of studies in which there was no difference between the sD-PPV and Del-PPV clinical outcomes. 
risk difference was the risk (of an adverse clinical outcome, such as rD) for Del-PPV patients minus the risk for sD-PPV patients. Positive numbers favor sD-PPV. negative 
numbers favor Del-PPV. The null hypothesis for the z-tests was that the risk difference was equal to zero.
Abbreviations: CI, confidence interval; CME, cystoid macular edema; DEL, delayed; IOI, intraocular inflammation/infection; IOP, increased intraocular pressure; PPV, pars 
plana vitrectomy; rD, retinal detachment; riskDiff, risk difference; sD, same day; Va, visual acuity.Clinical Ophthalmology 2014:8 submit your manuscript | www.dovepress.com
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same-day versus delayed vitrectomy outcomes for lens fragments
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Vanner and stewart
the DEL-PPV. These analyses did not include CME and 
intraocular inflammation/infection because for these out-
comes, there were no significant or marginally significant 
differences between SD-PPV and DEL-PPV in the MCF+ 
studies (Table 4).
Delayed vitrectomy time periods and data issues
Five DEL-PPV time periods (after cataract surgery) were 
analyzed. Three time periods were considered “prompt” 
DEL-PPV (3 to 7, 3 to 14, and 7 to 14 days after cataract 
surgery), and two time periods were considered “non-
prompt” DEL-PPV (7 or more days and 15 or more days 
after cataract surgery. For studies that provided individual 
patient data (including the exact day postcataract surgery 
of the vitrectomy), the time periods were exact. However, 
for studies that provided data grouped into time intervals, 
the time periods were based on average (often estimated) 
times. For these studies, some vitrectomies done on days 
1 and 2 after cataract surgery (previously determined to 
be time needed for the eye to “recover” from cataract 
surgery)13 may have been included in the 3 to 7 and 3 to 
14 days, data, and some vitrectomies done in weeks 3   
and 4 after cataract surgery may have been included in the 
3 to 14 and 7 to 14 days, data. This occurred as long as the 
average delay was within these time periods because it was 
impossible to separate the grouped results.
In addition, not every study provided data for each 
time period. For example, in some studies, no vitrectomies 
were performed 3 to 7 days after cataract surgery. For 
each outcome (not good VA, bad VA, retinal detachment, 
increased IOP, and corneal edema), an initial analysis was 
performed to estimate a summary effect (risk difference) 
comparing SD-PPV to various DEL-PPV time periods, 
including all MCF+ studies with data for any of the DEL-
PPV time periods. Summaries of these results are found in 
the shaded areas of Table 5. Three subsequent analyses were 
performed, using only studies that had data for all the time 
periods being compared. One analysis compared SD-PPV 
to DEL-PPV performed 3 to 7, 7 to 14, and 15+ days after 
cataract surgery. The second analysis compared SD-PPV 
to DEL-PPV performed 3 to 7 and 7+ days after cataract 
surgery. The third analysis compared SD-PPV to DEL-PPV 
performed 3 to 14 and 15+ days after cataract surgery. Sum-
maries of these results are found in the unshaded areas of 
Not good VA (<20/40) risk differences of SD- and DEL-PPV by MCF+/MCF–
Group by MCF policy Study ID
Point
estimate
Lower
limit
Upper
limit Z-value P-value
Ross 19936
Stilma et al 199726
Watts et al 200029
Yang et al 200212
Stefaniotou et al 200314
Tajunisah and Reddy 200715
Colyer et al 201134
Chiang et al 20123
Tommila and Immonen 199527
Borne et al 199618
Stenkula et al 199819
Verma et al 200140
Hansson and Larsson 200211
Kaynak et al 20062
Ruiz-Moreno et al 200617
Romero-Aroca et al 200725
Chen et al 200824
Konstantopoulos et al 200930
Vanner et al 201235
Modi et al 201332
MCF–
MCF–
MCF–
MCF–
MCF–
MCF–
MCF–
MCF–
MCF–
MCF+
MCF+
MCF+
MCF+
MCF+
MCF+
MCF+
MCF+
MCF+
MCF+
MCF+
MCF+
MCF+
Overall
0.556
–0.263
–0.046
–0.565
0.319
–0.125
0.066
–0.071
0.021
–0.054
–0.187
0.029
1.000
0.046
0.091
–0.375
0.357
0.362
0.303
0.199
0.029
0.162
0.086
–0.477
–0.661
–0.448
–1.563
–0.005
–0.551
–0.080
–0.490
–0.122
–0.490
–0.596
–0.703
0.434
–0.342
–0.477
–1.070
0.043
0.153
–0.169
–0.127
–0.070
0.008
–0.019
1.588
0.135
0.356
0.432
0.644
0.301
0.211
0.347
0.164
0.383
0.222
0.762
1.566
0.434
0.659
0.320
0.670
0.570
0.775
0.525
0.129
0.315
0.191
0.292
0.195
0.822
0.267
0.054
0.565
0.375
0.738
0.775
0.810
0.370
0.937
0.001
0.816
0.754
0.290
0.026
0.001
0.209
0.231
0.563
0.039
0.107
–1.00 –0.50 0.00 0.50 1.00
1.055
–1.296
–0.225
–1.111
1.930
–0.576
0.888
–0.335
0.285
–0.240
–0.896
0.079
3.464
0.232
0.314
–1.057
2.229
3.396
1.257
1.198
0.579
2.059
1.612
Statistics for each study Point estimate and 95% CI
Favors DEL-PPV Favors SD-PPV
All MCF–
All MCF+
Figure 3 Forest plot of a not good Va (,20/40) mixed-effects model for risk differences comparing sD-PPV and Del-PPV, separately for MCF+ and MCF- studies.
Notes: risk difference was the risk for Del-PPV patients minus the risk for sD-PPV patients. Positive numbers favor sD-PPV. negative numbers favor Del-PPV. squares 
(size proportional to study weight in the meta-analysis) indicate the estimated risk difference from each individual study, with lines indicating the 95% Ci. The red diamond 
is centered at the overall (all studies’) summary estimate of the risk difference. The upper black diamond is centered at the MCF- studies’ summary estimate of the risk 
difference, and the lower black diamond is centered at the MCF+ studies’ summary estimate. each diamond spans its 95% Ci.
Abbreviations: CI, confidence interval; DEL, delayed; ID, identification; MCF, Mayo Clinic Florida; MCF-, studies not adhering to MCF sD-PPV policies; MCF+, studies 
adhering to MCF sD-PPV policies; PPV, pars plana vitrectomy; sD, same day; Va, visual acuity.Clinical Ophthalmology 2014:8 submit your manuscript | www.dovepress.com
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prompt DEL-PPV (3 to 7, 3 to 14, or 7 to 14 days after 
cataract surgery). Of the 35 total comparisons of immediate 
SD-PPV and prompt DEL-PPV, only one (3%) (favoring 
immediate SD-PPV) was statistically significant, nine (26%) 
had P-values between 0.05 and 0.50 (eight [23%] favoring 
immediate SD-PPV and one favoring prompt DEL-PPV), 
and 25 (71%) had P-values greater than 0.50, providing 
little evidence of an association between clinical outcomes 
and immediate SD-PPV or prompt DEL-PPV. Based on 
this lack of a consistent pattern in comparisons of immedi-
ate SD-PPV and prompt DEL-PPV, there is a preliminary 
indication that prompt DEL-PPV produces outcomes 
that are similar to those produced by immediate SD-PPV 
(Figures 4A and 5).
same-day vs nonprompt delayed vitrectomies
However, all 25 results comparing immediate SD-PPV 
to nonprompt DEL-PPV (7+ and 15+ days after cataract 
surgery) favored immediate SD-PPV with eight (32%) 
statistically significant, 14 (56%) with P-values between 
0.05 and 0.50, and three (12%) with P-values greater than 
0.50. None favored nonprompt DEL-PPV. This provides a 
preliminary indication that nonprompt DEL-PPV produces 
outcomes that may be inferior to those from immediate SD-
PPV (Figures 4B and 5).
results summary
The SD-PPV vs DEL-PPV results are summarized in 
Figure 6, for all studies (Figure 6A) and separately for 
MCF+ (Figure 6B) and MCF- studies (Figure 6C). For all 
studies together and for the MCF- studies, the results did 
not indicate an association between clinical outcomes and 
whether the patient had an SD-PPV or DEL-PPV. However, 
there was evidence that immediate SD-PPV (MCF+ studies) 
may produce better outcomes than DEL-PPV. These results 
were robust in analyses for publication/reporting biases and 
all sensitivity analyses (results not shown).21
Comparisons of immediate SD-PPV with prompt or 
nonprompt DEL-PPV cannot be considered conclusive, 
due to small samples, but were congruent with results from 
our previous meta-analyses.13 Comparisons of immedi-
ate SD-PPV and prompt DEL-PPV did not consistently 
favor either vitrectomy time. This supports a preliminary 
hypothesis that patients who receive a prompt DEL-PPV 
might enjoy outcomes that are comparable with those who 
receive an immediate SD-PPV. However, all comparisons 
of immediate SD-PPV and nonprompt DEL-PPV favored 
SD-PPV.
Table  5  same-day  versus  delayed  vitrectomy  meta-analysis 
results (mixed-effects models) summary ranges of risk differences 
by  timing  of  delayed  vitrectomy  (prompt  vs  nonprompt)  for 
MCF+ articles only
Outcome Range in risk differences between  
SD- and DEL-PPV
Prompt  
DEL-PPV
Nonprompt 
DEL-PPV
Low High Low High
not good Va (,20/40) 1.90% 6.50% 11.90% 22.60%
-19.90% 6.20% 8.20% 22.60%
Bad Va (#20/200) 2.20% 7.40% 11.70% 13.10%
-6.90% 2.80% 11.70% 13.10%
rD -0.10% 7.40% 10.60% 12.90%
-0.20% 3.90% 10.60% 12.90%
iOP/glaucoma -0.10% 22.20% 13.80% 20.80%
-3.40% 1.40% 13.80% 18.30%
Corneal edema 2.80% 4.30% 8.50% 14.30%
0.00% 2.80% 9.10% 14.30%
Notes: risk difference was the risk (of an adverse clinical outcome, such as rD) 
for Del-PPV patients minus the risk for sD-PPV patients. Positive numbers favor 
sD-PPV. negative numbers favor Del-PPV. shaded areas have results for analyses 
using articles with data for any of the time periods, while unshaded areas have 
results for analyses using only articles that had data for all time periods. nonprompt 
delayed vitrectomies occurred 7 or more or 15 or more days after cataract surgery. 
Prompt delayed vitrectomies occurred 3 to 7, 3 to 14, or 7 to 14 days after cataract 
surgery. all comparisons between same-day vitrectomies and nonprompt delayed 
vitrectomies favor same-day vitrectomies, while results of comparisons between 
same-day vitrectomies and prompt delayed vitrectomies were mixed.
Abbreviations: Del, delayed; iOP, increased intraocular pressure; MCF, Mayo 
Clinic Florida; MCF+, articles adhering to MCF sD-PPV policies; PPV, pars plana 
vitrectomy; rD, retinal detachment; sD, same day; Va, visual acuity; vs, versus.
Table 5. These subsequent comparisons were done because 
there was a reasonable amount of heterogeneity (ie, between-
study variability in effects [see the I-squared statistics in 
Table 4]) in some of the initial MCF+ analyses.
Because the above analyses compared the results for imme-
diate SD-PPVs to only a subset of the DEL-PPVs for each study, 
the sample size and number of events was often quite small, and 
there were many studies with no events (or nonevents) in one or 
both treatment groups. In particular, some corneal edema results 
were based on only one or two MCF+ studies. Therefore, these 
results are preliminary and not conclusive.
Detailed results (discussed below) for these analyses are 
not shown but are available on request. Figure 4A shows the 
median and range of the estimated risk differences for imme-
diate SD-PPV (MCF+) vs prompt DEL-PPV, and Figure 4B 
provides the same information for immediate SD-PPV vs 
nonprompt DEL-PPV.
same-day vs prompt delayed vitrectomies
Overall, these results (Figure 4A) show no consistent pattern 
of risk differences favoring either immediate SD-PPV or Clinical Ophthalmology 2014:8 submit your manuscript | www.dovepress.com
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Discussion
Patient displeasure is common following complicated 
cataract surgery46,47 and tends not to improve if reduced VA 
persists.48 One article reported that, “Most patients [with 
retained lens fragments], who had expected a rapid visual 
recovery after cataract surgery, were very dissatisfied with 
poor vision postoperatively.”27 SD-PPV could help to miti-
gate this patient dissatisfaction.49
Some authors have suggested that cataract surgery on eyes 
with increased risk for retained lens fragments be performed at 
a facility where a vitreoretinal surgeon is available.28 One author 
extended this recommendation to any cataract surgeon learning 
phacoemulsification.50 Our results do not support these sugges-
tions for all cataract surgery patients (although future research 
may support these for patients with specific risk factors). As 
long as the cataract surgeon refers the patient to a vitreoretinal 
surgeon in time for a prompt DEL-PPV (3 to 7 or perhaps 
14 days after cataract surgery), our results provide support for 
current cataract surgery practice patterns and locations.
Previously reported results for SD-PPV were mixed.23 
Some facilities had good VA results,22,24,25 while other facili-
ties’ results were not as good.26–28 In one study, six SD-PPV 
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Figure 5 indications, from risk differences comparing sD-PPV to prompt and nonprompt Del-PPV, of which PPV timing produced better clinical outcomes.
Notes: 15+ = nonprompt Del-PPV 15 or more days after cataract surgery; 3 to 14= prompt Del-PPV 3 to 14 days after cataract surgery; 3 to 7= prompt Del-PPV 3 to 
7 days after cataract surgery; 7+ = nonprompt Del-PPV more than 7 days after cataract surgery; 7 to 14= prompt DEL-PPV 7 to 14 days after cataract surgery. The five 
outcomes were corneal edema, increased intraocular pressure/glaucoma, retinal detachment, bad visual acuity (#20/200), and not good visual acuity (,20/40). 
Abbreviations: Del, delayed; PPV, pars plana vitrectomy; sD, same day; vs, versus.
Median and range of risk differences
(MCF+ SD-PPV versus prompt DEL-PPV)
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Figure 4 Comparison of estimated risk differences for immediate sD (MCF+) vs prompt (3 to 7, 3 to 14, or 7 to 14 days after cataract surgery) Del-PPV (A) and nonprompt 
(7+ or 15+ days after cataract surgery) Del-PPV (B).
Notes: risk difference is the risk for Del-PPV patients minus the risk for sD-PPV patients. Positive numbers favor immediate sD-PPV. negative numbers favor Del-PPV. 
Column height indicates median estimated risk differences and error bars represent their range. (A) Nonsignificant, mixed results and large ranges support a preliminary 
hypothesis of similar outcomes for immediate sD- and prompt Del-PPV. (B) Several significant results favoring SD-PPV support previous research that earlier DEL-PPV 
produces better outcomes.
Abbreviations: Ce, corneal edema; Del, delayed; iOP, increased intraocular pressure; MCF, Mayo Clinic Florida; MCF+, studies adhering to MCF sD-PPV policies; PPV, 
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Figure 6 Comparison of sD- vs Del-PPV risk differences for all studies (A), MCF+ studies (B), and MCF- studies (C).
Notes: risk difference is the risk for Del-PPV patients minus the risk for sD-PPV patients. Positive numbers favor sD-PPV. negative numbers favor Del-PPV. Column height 
is the estimated risk difference; error bars span its 95% Ci. Ce results for MCF- studies (outlier not included).
Abbreviations: CE, corneal edema; CI, confidence interval; CME, cystoid macular edema; DEL, delayed; IOI, intraocular inflammation/infection; IOP, increased intraocular 
pressure; MCF, Mayo Clinic Florida; MCF-, studies not adhering to MCF sD-PPV policies; MCF+, studies adhering to MCF sD-PPV policies; PPV, pars plana vitrectomy; rD, 
retinal detachment; sD, same day; Vab, bad visual acuity (#20/200); Vang, not good Va (,20/40).
patients had cataract surgery done at a facility with a vitreo-
retinal unit: one had a massive choroidal hemorrhage, and 
another had corneal decomposition, possibly “related to 
prolonged use of intraocular fluids”.26 Elsewhere, excessive 
use of infusion fluid was contraindicated to prevent traction 
and retinal complications.6 One study reported no retinal 
detachments among 38 patients who received an SD (or 
next-day) vitrectomy,31 while, in another study, four of six 
SD-PPV patients had a retinal detachment.18
The reasons for inconsistent SD-PPV results are not 
clear, but based on our results, part of the explanation may be 
that policies and strategies for SD-PPV differ. It is possible 
that immediate SD-PPV, when cataract surgeons do not attempt 
retained lens fragment retrieval, produces superior results,35 but 
other SD-PPV strategies may not be as good. Perhaps immedi-
ate SD-PPV removes the lens fragments before the onset of 
time-dependent inflammation and the accompanying choroidal 
congestion that occurs with same-day patient transfer between 
surgical facilities. Immediate SD-PPV for retained lens frag-
ments closely resembles a planned pars plana lensectomy, 
something frequently performed, without complications, by 
vitreoretinal surgeons. Compared with waiting several hours 
between surgeries, immediate SD-PPV may take advantage 
of a clear cornea and minimally inflamed eye to enable better 
removal of retained lens fragments, with fewer complications. 
Reasons for inconsistent SD-PPV results might also include 
characteristics of the eyes and/or surgeons, which could not 
be explored in a meta-analysis using study-level data.
These results support our previous research on vitrectomy 
timing. Our previous analysis of MCF SD-PPV vs DEL-PPV 
data35 indicated that immediate SD-PPV was associated with 
superior clinical outcomes. Our previous meta-analysis, 
which assessed the effect of increasing vitrectomy delays 
(3 or more days after cataract surgery), indicated that prompt 
DEL-PPV outcomes were superior to later (nonprompt) 
DEL-PPV outcomes.13 The current meta-analysis indicated 
that immediate SD-PPV was associated with superior clini-
cal outcomes compared with all and nonprompt DEL-PPV 
but that prompt DEL-PPV was associated with outcomes 
comparable with immediate SD-PPV.
Future research
This leads to a hypothesis that immediate SD-PPV and 
prompt DEL-PPV may produce equivalent outcomes. Clinical Ophthalmology 2014:8 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
2274
Vanner and stewart
A multicenter, randomized controlled trial would be needed 
to test a noninferiority hypothesis comparing immediate 
SD-PPV and prompt DEL-PPV outcomes. Although the 
MCF policy is one alternative, different facilities may have 
other successful SD-PPV policies. Further research should 
analyze how SD-PPV results differ based on various SD-
PPV strategies, to determine the optimal circumstances for 
an SD-PPV.
study limitations
Major limitations include low power due to few patients 
with adverse events, especially in the SD-PPV group, which 
was generally much smaller than the DEL-PPV group, and 
especially in the MCF+ studies (Table 3). Another limitation 
was the classification of studies as MCF+ or MCF- based 
solely on information provided in each article (study-based). 
It is possible that some SD-PPV patients in the MCF- studies 
received an immediate SD-PPV, which would undermine the 
internal validity of MCF+/MCF- comparisons and understate 
any actual differences between these groups.51 Another pos-
sible threat to internal validity was selection bias51 because 
it was not possible to determine whether there were sig-
nificant between-group (SD-PPV vs DEL-PPV) differences 
in baseline variables. Comparisons of immediate SD-PPV 
and prompt DEL-PPV (3 to 7, 3 to 14, or 7 to 14 days after 
cataract surgery) were affected by data grouped into time 
intervals, so data from DEL-PPV performed outside these 
time periods were included in some analyses.
Several additional limitations to meta-analysis of these 
data were discussed previously.13 As with our previous meta-
analysis, this one had little evidence of publication bias, 
but the studies did exhibit reporting bias, and it is possible 
that authors were more likely to report significant, rather 
than nonsignificant, results. However, sensitivity analyses 
indicated that the overall conclusions were not affected by 
reporting bias, the inclusion of small studies and those with 
no events (or nonevents) in a treatment group, or the removal 
of any one study from the analyses.21
Clinical recommendations
The question of whether SD-PPV for retained lens frag-
ments is appropriate has long been debated by vitreoretinal 
surgeons, with many firmly on one side (in favor of SD-PPV) 
and others just as firmly on the other. This research raises 
the possibility that this lack of consensus may have occurred 
because all SD-PPVs cannot be considered as the same clini-
cal option. There appears to be at least two distinct variations 
of SD-PPV: immediate SD-PPV performed under strategies 
such as the MCF “no move, no wait” policy35 and SD-PPV 
performed under different strategies that permit longer waits 
and/or interfacility patient transport.
Some ophthalmologists who support SD-PPV may have 
had good clinical experience with immediate SD-PPV com-
pared with DEL-PPV that occurred weeks, months, or even 
years after cataract surgery. On the other hand, it is possible 
that some ophthalmologists who do not support SD-PPV 
have had experiences with SD-PPV after long delays and/or 
interfacility patient transport that were not as positive. This 
meta-analysis may help inform the SD-PPV debate with the 
contribution that while SD-PPV may be appropriate under 
some policies (for example, immediately with no waiting or 
interfacility patient transport), SD-PPV may often be inap-
propriate under other policies.
Conclusion
This research provides some preliminary evidence that 
SD-PPV may be unnecessary as long as prompt DEL-PPV 
would be performed. Some cataract surgery practice pat-
terns can accommodate either immediate SD-PPV or prompt 
DEL-PPV because the cataract surgeons operate at the same 
facility as a vitreoretinal surgeon, but most operate where a 
vitreoretinal surgeon is not readily available. These results, 
coupled with the results of our previous meta-analysis, pro-
vide a preliminary indication that if an immediate SD-PPV 
cannot be performed, the cataract surgeon need not attempt 
to transfer the patient to another facility for an SD-PPV, but 
should refer the patient to a vitreoretinal surgeon so that a 
prompt DEL-PPV can be performed.
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Supplementary materials
First search
 1 retained lens  3 dislocated lens  5 posterior dislocation of lens
 2 dropped nucleus  4 intravitreal lens  6 #1 or #2 or #3 or #4 or #5
limits: english, January 1, 1985 (year of the initial journal article on this subject) to October 31, 2009, with updates weekly through the “My nCBi” 
service of PubMed. Outcomes were not included based on recommendations for search strategies in the Cochrane Handbook for Systematic Review of 
Interventions.1
Second search
 1 lens fragments 11 retina detachment 21 intraocular infection
 2 dropped nuclei 12 glaucoma 22 intra-ocular infection
 3 retained nuclei 13 intraocular pressure 23 endophthalmitis
 4 nuclear fragments 14 intra-ocular pressure 24 hypopyon
 5 lens dislocation 15 intra-ocular inflammation 25 corneal edema
 6 lens material 16 intraocular inflammation 26 cornea edema
 7 #1 or #2 or #3 or #4 or #5 or #6 17 uveitis 27 cystoid macular edema
  8  visual acuity
  9  visual outcome
10  retinal detachment
18
19
20
vitritis
AC inflammation
anterior chamber inflammation
28 #8 or #9 or #10 or #11 or #12 or #13 or 
#14 or #15 or #16 or #17 or #18 or #19 or 
#20 or #21 or #22 or #23 or #24 or #25 or 
#26 or #27
29 #7 and #28
limits: english, January 1, 1985 to July 30, 2010, with updates weekly through the “My nCBi” service of PubMed. Outcomes included because the 
term “nuclear fragments” returned many studies about cell nuclei.
Updated search methods for identification of studies (MEDLINE/PubMed).
Updated second search
 1 lens fragments 11 retina detachment 21 intraocular infection
 2 dropped nuclei 12 glaucoma 22 intra-ocular infection
 3 retained nuclei 13 intraocular pressure 23 endophthalmitis
 4 nuclear fragments 14 intra-ocular pressure 24 hypopyon
 5 lens dislocation 15 intra-ocular inflammation 25 corneal edema
 6 lens material 16 intraocular inflammation 26 cornea edema
 7 #1 or #2 or #3 or #4 or #5 or #6 17 uveitis 27 cystoid macular edema
  8  visual acuity
  9  visual outcome
10  retinal detachment
18 vitritis 28 #8 or #9 or #10 or #11 or #12 or #13 or 
#14 or #15 or #16 or #17 or #18 or #19 or 
#20 or #21 or #22 or #23 or #24 or #25 or 
#26 or #27
19 AC inflammation
20 anterior chamber inflammation
29 #7 and #28
limits: english, July 1, 2010 to July 16, 2013, with updates weekly through the “My nCBi” service of PubMed. Outcomes included because the term 
“nuclear fragments” returned many studies about cell nuclei.
Figure S1 Original search methods for identification of studies (MEDLINE/PubMed).
Abbreviations: aC, anterior chamber; nCBi, national Center for Biotechnology information.
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